Reduced ovarian reserve in patients with adult polymyositis

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER LONDON LTD
Citação
CLINICAL RHEUMATOLOGY, v.34, n.10, p.1795-1799, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Polymyositis (PM) affects female gender during reproductive age; however, there is no study assessing ovarian reserve in these patients to evaluate ovarian reserve markers in PM. Eight female patients with PM (Bohan and Peter criteria, 1975) with aged 18-40 years, followed at our tertiary centre from March 2011 to May 2014, were invited to participate. They were age-matched with 16 healthy individuals (control group). All were evaluated at early follicular phase of menstrual cycle. Follicle stimulating hormone (FSH), estradiol, inhibin B, anti-Mullerian hormone (AMH) serum levels (ELISA) and sonographic antral follicle count (AFC) were determined. PM patients and controls had comparable mean age (31.4 +/- 6.5 vs. 30.7 +/- 6.2 years, P = 0.946), ethnicity and socioeconomic class (P > 0.05). PM mean age of onset was 27.3 +/- 6.5 years and disease duration of 6.5 +/- 4.1 years. Menstrual cycles were alike in both groups with a similar frequency of age at menarche, gynaecological age, duration and length of menstrual cycle (P > 0.05). The median serum level of AMH was significantly lower in PM compared to controls [0.7(0.3-3.4) vs. 3.1(1.4-4.0), P = 0.021]. AMH levels a parts per thousand currency sign1 ng/mL (50 vs. 6.3 %, P = 0.024) and very low AFC (37.5 vs. 6.3 %, P = 0.037) were significantly in PM patients versus controls. The other hormones (FSH, inhibin B and estradiol levels) were similar between both groups (P > 0.05). The present study was the first to identify subclinical ovarian dysfunction in PM patients during reproductive ages. Further study is necessary to assess the possible role of PM-related factors that may influence the ovarian function of these patients.
Palavras-chave
Anti-Mullerian hormone, Antral follicle count, Idiopathic inflammatory myopathies, Ovarian reserve, Polymyositis
Referências
  1. Almeida PM, 1991, CRITERIO CLASSE EC A, P1
  2. Silva CA, 2010, ARTHRIT CARE RES, V62, P1682, DOI 10.1002/acr.20323
  3. Yamakami LYS, 2014, LUPUS, V23, P862, DOI 10.1177/0961203314529468
  4. Clark CA, 2014, HUM REPROD, V29, P184, DOI 10.1093/humrep/det413
  5. Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fernstert.2004.10.011
  6. Mont'Alverne ARS, 2015, CLIN RHEUMATOL, V34, P179, DOI 10.1007/s10067-014-2680-5
  7. Silva CAA, 2002, LUPUS, V11, P419, DOI 10.1191/0961203302lu219oa
  8. Ghaleb RM, 2013, JOINT BONE SPINE, V80, P434, DOI 10.1016/j.jbspin.2012.10.016
  9. BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706
  10. Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042
  11. KERR GS, 1994, ANN INTERN MED, V120, P919
  12. Kallio S, 2013, FERTIL STERIL, V99, P1305, DOI 10.1016/j.fertnstert.2012.11.034
  13. Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1
  14. Aikawa NE, 2012, CLIN EXP RHEUMATOL, V30, P445
  15. Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042
  16. Silva CAA, 2007, LUPUS, V16, P593, DOI 10.1177/096120330707077538
  17. Aikawa NE, 2010, CLIN EXP RHEUMATOL, V28, P571
  18. Appenzeller S, 2008, RHEUMATOL INT, V28, P567, DOI 10.1007/s00296-007-0478-3
  19. Araujo D, 2014, SCAND J RHEUMATOL, V43, P503
  20. Bruce Bonnie, 2003, Health Qual Life Outcomes, V1, P20, DOI 10.1186/1477-7525-1-20
  21. Greenberg SA, 2008, SEMIN NEUROL, V28, P241, DOI 10.1055/s-2008-1062267
  22. Koninger A, 2015, GYNECOL ENDOCRINOL, V31, P26, DOI 10.3109/09513590.2014.959436
  23. Legg AT, 1932, PRINCIPLES PRACTICE
  24. Lukaszuk K, 2014, GINEKOL POL, V85, P778
  25. Mont'Alverne ARS, 2014, J RHEUMATOL, V41, P2055, DOI 10.3899/jrheum.131360
  26. Satwik Ruma, 2012, J Hum Reprod Sci, V5, P206, DOI 10.4103/0974-1208.101023
  27. Souza FHC, 2015, CLIN EXP RHEUMATOL, V33, P44